← Back to Calendar
Live Company Data
NMS
Updated
just now
· Data: FMP
Current Price
$10.18
+34.12%
+$2.59 today
Day: $10.00 – $10.33
52-Week Range
Current price is at 50% of 52-week range
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Q1 2026 earnings + vepdegestrant PDUFA June 5 preparation update
Key Notes
Q1 2026 earnings expected ~May 7, 2026. Critical update ahead of June 5 vepdegestrant PDUFA date — commercial readiness, Pfizer partnership dynamics, label expectations. Also expected: update on ARV-766 (PROTAC AR degrader) for prostate cancer and broader pipeline.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.